Literature DB >> 24703999

A novel murine CTP:phosphoethanolamine cytidylyltransferase splice variant is a post-translational repressor and an indicator that both cytidylyltransferase domains are required for activity.

Zvezdan Pavlovic1, Ratnesh Kumar Singh2, Marica Bakovic2.   

Abstract

CTP:phosphoethanolamine cytidylyltransferase (Pcyt2) has an important regulatory function in biosynthesis of the membrane phospholipid phosphatidylethanolamine. We previously determined that the full-length Pcyt2α and its splice variant Pcyt2β are the main active isoforms of this enzyme. Here we report that mouse Pcyt2 could be spliced at Introns 7 and 8 to produce a unique third isoform, Pcyt2γ, in which the second cytidylyltransferase domain at the C-terminus becomes deleted. Pcyt2γ is ubiquitously expressed in embryonic and adult mouse tissues, and is the most abundant in the kidney, skeletal muscle and testis. Pcyt2γ splicing mechanism dominates over Pcyt2β exon-skipping mechanism in most examined tissues. Although Pcyt2γ maintains the N-terminal cytidylyltransferase domain as most cytidylyltransferases, the lack of the C-terminal cytidylyltransferase domain causes a complete loss of catalytic activity. However, Pcyt2γ interacts with the active isoform, Pcyt2α, and significantly reduces Pcyt2α homodimerization and activity. The inactive N-domain (H35Y, H35A) and C-domain (H244Y, H244A) mutants of Pcyt2α also reduce Pcyt2α homodimerization and activity. This study revealed the importance of both cytidylyltransferase (35)HYGH and (244)HIGH motifs for the activity of murine Pcyt2α and established that the naturally occurring splice variant Pcyt2γ has a function to restrain the enzyme activity through the formation of unproductive enzyme complexes.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dimerization; Dominant negative; Kennedy pathway; Phosphatidylethanolamine; Phospholipids

Mesh:

Substances:

Year:  2014        PMID: 24703999     DOI: 10.1016/j.gene.2014.04.005

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Molecular Mechanism for the Thermo-Sensitive Phenotype of CHO-MT58 Cell Line Harbouring a Mutant CTP:Phosphocholine Cytidylyltransferase.

Authors:  Lívia Marton; Gergely N Nagy; Olivér Ozohanics; Anikó Lábas; Balázs Krámos; Julianna Oláh; Károly Vékey; Beáta G Vértessy
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

2.  Mutations in PCYT2 disrupt etherlipid biosynthesis and cause a complex hereditary spastic paraplegia.

Authors:  Frédéric M Vaz; John H McDermott; Mariëlle Alders; Saskia B Wortmann; Stefan Kölker; Mia L Pras-Raves; Martin A T Vervaart; Henk van Lenthe; Angela C M Luyf; Hyung L Elfrink; Kay Metcalfe; Sara Cuvertino; Peter E Clayton; Rebecca Yarwood; Martin P Lowe; Simon Lovell; Richard C Rogers; Antoine H C van Kampen; Jos P N Ruiter; Ronald J A Wanders; Sacha Ferdinandusse; Michel van Weeghel; Marc Engelen; Siddharth Banka
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

3.  Axonal Polyneuropathy in 2 Brothers With a Homozygous Missense Variant in the First Catalytic Domain of PCYT2.

Authors:  Lea Leonardis; Marusa Skrjanec Pusenjak; Ales Maver; Helena Jaklic; Ana Ozura Brecko; Blaz Koritnik; Borut Peterlin; Karin Writzl
Journal:  Neurol Genet       Date:  2022-03-01

4.  Pcyt2 deficiency causes age-dependant development of nonalcoholic steatohepatitis and insulin resistance that could be attenuated with phosphoethanolamine.

Authors:  Sophie Grapentine; Rathnesh K Singh; Poulami Basu; Sugashan Sivanesan; Gabriela Mattos; Oreoluwa Oresajo; Jasmine Cheema; Wendwesen Demeke; Vernon W Dolinsky; Marica Bakovic
Journal:  Sci Rep       Date:  2022-01-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.